iTeos Therapeutics, Inc. (18)
Browse by Contract Category
Contracts
-
Third Amended and Restated Collaboration Agreement between iTeos Belgium SA and Adimab, LLC, dated February 22, 2021
(Filed With SEC on May 13, 2021)
-
Description of Securities
(Filed With SEC on March 24, 2021)
-
Employment Agreement between the Registrant and Michel Detheux, Ph.D., to be in effect upon the completion of this offering
(Filed With SEC on July 20, 2020)
-
Form of Specimen Common Stock Certificate
(Filed With SEC on July 20, 2020)
-
Form of Employee Confidentiality, Assignment, Nonsolicitation and Noncompetition Agreement
(Filed With SEC on July 20, 2020)
-
Employment Agreement between the Registrant and Matthew Gall, to be in effect upon the completion of this offering
(Filed With SEC on July 20, 2020)
-
Employment Agreement between the Registrant and Joanne Jenkins Lager, M.D., to be in effect upon the completion of this offering
(Filed With SEC on July 20, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on July 20, 2020)
-
Form of Director Indemnification Agreement
(Filed With SEC on July 20, 2020)
-
Form of Officer Indemnification Agreement
(Filed With SEC on July 20, 2020)
-
Senior Executive Cash Incentive Bonus Plan
(Filed With SEC on July 20, 2020)
-
2020 Employee Stock Purchase Plan
(Filed With SEC on July 20, 2020)
-
Master Services Agreement between iTeos Belgium and WuXi Biologics (Hong Kong) Limited, dated March 21, 2017
(Filed With SEC on July 20, 2020)
-
2020 Stock Option and Incentive Plan, and forms of award agreements thereunder
(Filed With SEC on July 20, 2020)
-
Employment Agreement between the Registrant and Matthew Call, to be in effect upon the completion of this offering
(Filed With SEC on July 20, 2020)
-
Amended and Restated Stockholders Agreement, dated as of March 24, 2020
(Filed With SEC on June 24, 2020)
-
2019 Stock Option and Grant Plan, and forms of award agreements thereunder
(Filed With SEC on June 24, 2020)
-
Second Amended and Restated Collaboration Agreement between iTeos Belgium SA and Adimab, LLC, dated July 23, 2018
(Filed With SEC on June 24, 2020)
